Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment

Leukemia. 2023 Oct;37(10):2129-2132. doi: 10.1038/s41375-023-02008-6. Epub 2023 Aug 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Polycythemia Vera* / drug therapy
  • Progression-Free Survival
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins